Abstract: The present disclosure provides a data aggregation processing apparatus and method, and a storage medium. According to the apparatus, a relatively complex target data sequence may be split, by a sequence grouping module, into a plurality of subsequences, which then can be subjected to simultaneous aggregation processing in a parallel processing mode by means of a plurality of parallel aggregation modules included in an aggregation module group, so as to obtain corresponding intermediate processing results. Subsequently, the intermediate processing results are merged by a merging module to obtain an aggregation processing result for the target data sequence. Aggregation processing for the target data sequence is completed, thus solving the technical problems in the existing methods, such as low aggregation processing efficiency and prolonged processing procedure. The technical effects of improving the aggregation processing efficiency and shortening the waiting time of users are achieved.

Abstract: Provided are a database management method and apparatus based on a lookup table. The method comprises: acquiring a data management operation request; retrieving a three-level storage table in response to the data management operation request; and adjusting the three-level storage table according to an operation requested by the data management operation request, so as to obtain the adjusted three-level storage table, wherein the three-level storage table includes: a page information table of data; the column information table of data; and the data table for recording information of a piece of data by means of a row of data. By means of the method, the problem of the low efficiency of existing database management based on a lookup table is solved, and the aim of simply and efficiently carrying out a lookup table operation is thus achieved.

Abstract: Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.

Abstract: Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.

Abstract: Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.